COMMUNIQUÉS West-GlobeNewswire

Alcon confirms commitment to Switzerland ahead of proposed spinoff from Novartis
11/09/2018
Global headquarters to be co-located in Geneva alongside Alcon's Europe, Middle East and Africa regional office The listed Alcon company will be incorporated in Fribourg, where Alcon already has significant operations, [...]
Biocartis Group NV: Biocartis Creates New Warrant Plan
11/09/2018
PRESS RELEASE : REGULATED INFORMATION Tuesday, 11 September 2018, 07:00 CEST Biocartis Creates New Warrant Plan Mechelen, Belgium, 11 September 2018 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative [...]
Xenon Enters into Agreement to Buy Out Milestones and Royalties Related to its XEN1101 Program
11/09/2018
BURNABY, British Columbia, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage, neurology-focused biopharmaceutical company, today announced it has signed an agreement with [...]
CV Sciences, Inc. Achieves Industry’s First Hemp Extract GRAS Self-Affirmation
11/09/2018
First Hemp Extract to Achieve Highly Sought-After Self-Affirmed GRAS Status Designation LAS VEGAS, Sept. 10, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) [...]
Telix Completes Acquisition of Atlab for Prostate Cancer Program
11/09/2018
MELBOURNE, Australia and NANTES, France, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) today announced completion of the acquisition of Atlab Pharma SAS (“Atlab”). The option [...]
North Dakota’s first all-ages free dental care event coming to Bismarck
11/09/2018
Hundreds of volunteers to provide free dental services during Mission of Mercy at Bismarck Event Center, Sept. 28-29 BISMARCK, N.D., Sept. 10, 2018 (GLOBE NEWSWIRE) -- The North Dakota Dental Association and North [...]
SIGA Technologies Awarded BARDA Contract for TPOXX®
10/09/2018
- Contract Valued at Up to $629 Million – - Contract Includes Delivery of Oral and Intravenous (IV) Formulations of TPOXX; Development of IV TPOXX; Post-marketing Activities – NEW YORK, Sept. 10, 2018 (GLOBE NEWSWIRE [...]
BioSyent Announces Changes to Executive Management
10/09/2018
TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) today announced changes to its Executive Management team: Effective on September 10, 2018, Mr. Alfred D’Souza has [...]
ICU Medical, Inc. to Present at the 2018 Morgan Stanley Global Healthcare Conference
10/09/2018
SAN CLEMENTE, Calif., Sept. 10, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care [...]
SHIRE ANNOUNCES THE PRICING TERMS AND INCREASE IN THE MAXIMUM TENDER AMOUNT OF THE PREVIOUSLY ANNOUNCED CASH TENDER OFFERS FOR CERTAIN OUTSTANDING NOTES
10/09/2018
SHIRE ANNOUNCES THE PRICING TERMS AND INCREASE IN THE MAXIMUM TENDER AMOUNT OF THE PREVIOUSLY ANNOUNCED CASH TENDER OFFERS FOR CERTAIN OUTSTANDING NOTES Dublin, Ireland – September 10, 2018 –Shire plc (LSE: SHP and [...]
Helix BioPharma Corp. Closes Private Placement
10/09/2018
RICHMOND HILL, Ontario, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP)(FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
BioSig Technologies, Inc. Announces 1-for-2.5 Reverse Stock Split for Pending Uplist to Nasdaq
10/09/2018
Split-Adjusted Common Stock trading under BSGMD on September 11, 2018 Santa Monica, CA, Sept. 10, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM, OTCQB: BSGMD) (“BioSig” or the “Company”), a medical [...]
Clearside Biomedical to Participate in 2018 Janney Healthcare Conference
10/09/2018
ALPHARETTA, Ga., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
PLx Pharma Inc. to Present at Janney Healthcare Conference on September 18
10/09/2018
HOUSTON, Sept. 10, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Vazalore™ 325 [...]
ERYTECH Reports First Half of 2018 Financial Results and Provides Business Update
10/09/2018
Conference call and webcast scheduled for Tuesday, September 11 th at 2:30 pm CET/8:30 am EDT Strategic shift to development of eryaspase for solid tumors confirmed Phase 3 trial for eryaspase in second line pancreatic [...]
ERYTECH publie ses résultats financiers et fait le point sur ses activités du premier semestre 2018
10/09/2018
Conférence téléphonique et webcast : mardi 11 septembre à 14h30 Confirmation du virage stratégique entrepris vers le développement d’eryaspase dans les tumeurs solides Lancement de l’étude de Phase 3 avec eryaspase pour [...]
CRISPR Therapeutics, Intellia Therapeutics and Caribou Biosciences Provide Update on U.S Federal Circuit Decision Upholding the Ruling by U.S. Patent and Trademark Office in Interference Proceeding Relating to CRISPR/Cas9 Genome Editing Technology
10/09/2018
The interference proceeding remains terminated without any determination on inventorship of CRISPR/Cas9 genome editing application to eukaryotic cells University of California/University of Vienna/Dr. Charpentier have [...]
Endocyte Announces $175.0 Million Proposed Public Offering of Common Stock
10/09/2018
WEST LAFAYETTE, Ind., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq Global Market:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, announced today that [...]
Avid Bioservices Reports Financial Results for First Quarter Fiscal 2019 and Recent Developments
10/09/2018
-- F iscal 2019 Projected Revenue of $51 to $55 Million Reaffirmed -- -- Multiple Projects Advanced During the Quarter -- -- Initiated Operations of New Process Development Laboratories -- TUSTIN, Calif., Sept. 10, 2018 [...]

Pages